Endocrinology, Vol 124, 870-877, Copyright © 1989 by Endocrine Society

ARTICLES

Identification of a family of insulin-like growth factor II secreted by cultured rat epithelial-like cell line 18,54-SF: application of a monoclonal antibody

H Tanaka, O Asami, T Hayano, I Sasaki, Y Yoshitake and K Nishikawa
Department of Biochemistry, Kanazawa Medical University, Ishikawa, Japan.

Somatomedin/insulin-like growth factor (IGF)-like polypeptides (designated SMP) were purified from the serum-free conditioned medium of cultured rat epithelial-like cells, 18,54-SF. A monoclonal antibody (MAb) was produced against partially purified SMP. The antibody was immunoglobulin G1 relatively specific for multiplication-stimulating activity III-2 (rat IGF-II), with a Kd value of 5.6 X 10(-9) M. The antibody showed 100% cross-reactivity with human IGF-II and 10% cross- reactivity with human IGF-I, but did not cross-react with insulin. For purification of SMP, therefore, immunoaffinity chromatography on Sepharose coupled with the MAb was used besides a procedure including ion exchange chromatography, gel filtration, and reverse phase HPLC. The purified SMP (at least five polypeptides) each gave a single peak on reverse phase HPLC and appeared as a single band with an apparent mol wt of 5000-8000 on sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The major components of SMP (designated HP1-SMP and HP3-SMP), which were purified about 100-fold from conditioned medium, stimulated DNA synthesis in human fibroblasts in culture and sulfation in chick embryonic cartilage in culture. These polypeptides showed almost the same cross-reactivity as multiplication-stimulating activity III-2 on RIA with the MAb. The partial amino acid sequences of HP1- and HP3-SMP were determined, and these polypeptides were identified with rat IGF-II.

This article has been cited by other articles:

				E. J. Kim, P. E. Holthuizen, H. S. Park, Y. L. Ha, K. C. Jung, and J. H. Y. Park Trans-10,cis-12-conjugated linoleic acid inhibits Caco-2 colon cancer cell growth Am J Physiol Gastrointest Liver Physiol, August 1, 2002; 283(2): G357 - G367. [Abstract] [Full Text] [PDF]

				H. Kiaris, A. V. Schally, J. L. Varga, K. Groot, and P. Armatis From the Cover: Growth hormone-releasing hormone: An autocrine growth factor for small cell lung carcinoma PNAS, December 21, 1999; 96(26): 14894 - 14898. [Abstract] [Full Text] [PDF]

				N. Lamharzi, A. V. Schally, M. Koppan, and K. Groot Growth hormone-releasing hormone antagonist MZ-5-156 inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of insulin-like growth factor II in tumors PNAS, July 21, 1998; 95(15): 8864 - 8868. [Abstract] [Full Text] [PDF]

				C. E. H. Stewart and P. Rotwein Insulin-like Growth Factor-II Is an Autocrine Survival Factor for Differentiating Myoblasts J. Biol. Chem., May 10, 1996; 271(19): 11330 - 11338. [Abstract] [Full Text] [PDF]

				R. Zarrilli, M. Romano, S. Pignata, S. Casola, C. B. Bruni, and A. M. Acquaviva Constitutive Insulin-like Growth Factor-II Expression Interferes with the Enterocyte-like Differentiation of CaCo-2 Cells J. Biol. Chem., April 5, 1996; 271(14): 8108 - 8114. [Abstract] [Full Text] [PDF]

				M M Lau, C E Stewart, Z Liu, H Bhatt, P Rotwein, and C L Stewart Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes & Dev., December 15, 1994; 8(24): 2953 - 2963. [Abstract] [PDF]